BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 18482435)

  • 1. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
    Schneider M
    Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia.
    Leweke FM
    Curr Top Behav Neurosci; 2009; 1():387-96. PubMed ID: 21104393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA; Lutz B
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
    Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
    Bossong MG; Niesink RJ
    Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and neurodevelopment: implications for psychiatric disorders.
    Sundram S
    Hum Psychopharmacol; 2006 Jun; 21(4):245-54. PubMed ID: 16783814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and psychosis: an update on course and biological plausible mechanisms.
    Linszen D; van Amelsvoort T
    Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system dysfunction in mood and related disorders.
    Ashton CH; Moore PB
    Acta Psychiatr Scand; 2011 Oct; 124(4):250-61. PubMed ID: 21916860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychopharmacology of delta-9-tetrahydrocannabinol].
    Costentin J
    Ann Pharm Fr; 2008 Aug; 66(4):219-31. PubMed ID: 18847570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
    Hungund BL; Basavarajappa BS
    Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabis and Schizophrenia: new findings in an old debate].
    Kawohl W; Rössler W
    Neuropsychiatr; 2008; 22(4):223-9. PubMed ID: 19080993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor.
    de Fonseca FR; Schneider M
    Addict Biol; 2008 Jun; 13(2):143-6. PubMed ID: 18482429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.